CVRI Visiting Professor:  Sunil Rao, MD

Sunil Rao, MD, is a Professor of Medicine with Tenure at Duke Health System, Section Chief of Cardiology at the Durham VA Medical Center, and an investigator at The Duke Clinical Research Institute.  He is also the Editor-In-Chief of Circulation Cardiovascular Interventions and is the Chair of the 2019 Annual Scientific Sessions for the Society for Cardiovascular Angiography and Interventions (SCAI)

His primary research interests are in pharmacological and interventional therapies for acute coronary syndromes, quality assessment and improvement in interventional cardiology, and bleeding and blood transfusion complications in patients with heart disease.

His events included a Medicine Grand Rounds program titled "Transradial Coronary Intervention: Improving PCI Safety in Women and Leveraging Social Media for Adoption"; a program for Cardiology fellows and faculty on "Bleeding and Blood Transfusion in Patients with Ischemic Heart Disease" a Twitter Workshop for Cardiovascular Clinical and Research Teams; meetings with faculty and fellows; and a dinner reception with members of the CVRI Board of Directors and the Early Career Committee

Mark Ray Rides (again) for Heart Health

For the past 17 years, Mark Ray, a member of CVRI's Cardiovascular Leadership Council, and his cycling and fundraising partner Steve Gronlund, have devoted countless hours of training and cycling to honor the memory of Mark's father--who died of heart disease at age 64-- and raise funds for heart disease research and prevention.

For this year's 18th annual Jim Ray Memorial Heart Ride, Mark (on the left) and Steve (center) were joined by Steve's boyhood friend Dan Nelson, who had heart surgery the previous October to repair a mitral valve.  The trio started at 4:45 a.m. in Saint-Jérôme, Quebec, just north of Montreal, and covered 200 miles (also known as a "double century") on a rails-to-trails route called Le P'tit Train du Nord through the Laurentian Mountains. Seventeen hours later (13 of them spent pedaling!) they returned to Saint-Jérôme.  Read more about their adventure here.

As in recent years, the funds raised from this ride will support CVRI programs.  If you'd like to make a donation and push this year's effort even further past the team's goal, please click here.

Developing a Career in Cardiovascular Science

CVRI's Early Career Advisory Committee sponsored a panel discussion by Larner College of Medicine alumni, who shared their career experiences with UVM's cardiovascular research community, trainees and students, and alumni visitors.  The panelists provided insights on how to develop a scientific career and, because of their diverse career paths, attendees heard different perspectives on collaborations, networking, and grantsmanship.  A networking reception followed the panel discussion.

Sincere thanks to our panelists:

Edward Havranek, MD '83, Professor, Division of Cardiology, University of Colorado School of Medicine and Director of Medicine, Denver Health.

Albert Sinusas, MD '83, Professor of Medicine (Cardiovascular Medicine) and Radiology and Biomedical Imaging, Yale University School of Medicine; Director, Yale Translational Research Imaging Center; Director, Advanced Cardiovascular Imaging, Yale New Haven Hospital.

David Warshaw, PhD '79, Professor and Chair, Department of Molecular Physiology and Biophysics, UVM Larner College of Medicine.

Marilyn Cipolla, PhD '97, Professor, Department of Neurological Sciences with joint appointments in the Departments of Obstetrics, Gynecology & Reproductive Sciences and Pharmacology, UVM Larner College of Medicine.

Twitter in Medical Research Session

CVRI's Early Career Advisory Committee hosted a hands-on Twitter Session with UVM Larner College of Medicine and UVM Medical Center's social media experts featuring a "how-to Twitter" start up tutorial, building research and clinical networks, and how to be part of the growing Twitter science community!

CVRI's Mary Cushman, MD also presented on how she utilizes Twitter to create network connections and utilize Twitter to facilitate meaningful science.

The event concluded with a spontaneous "Drop and Give Me 20" fitness shout out for science!

News and Announcements

Have a speaker you'd like to bring to campus?

for information on Visiting Professor funding available through CVRI. 

CVRI provides internal review of grant applications to support cardiovascular research. E-mail CVRI for more information.  *NOTE: The request for internal review must be made at least 6 weeks before the submission deadline.

CVRI Annual Report

AR for 2017_Cover View the Flipbook >>

Mark Your Calendars

CVRI's Early Career Advisory Committee will be hosting a Research Symposium on January 22, 2019.  Check back at a later date for additional details!

CVRI Travel Awards

CVRI travel awards are available to support trainees and junior investigators presenting abstracts at regional and national scientific meetings.  These competitive awards are for reimbursement of presentation-related expenses of up to $2,000; more details can be found on the application for funding


Editor-In-Chief for New Journal

The International Society on Thrombosis and Haemostasis (ISTH) recently announced the launch of its new open access journal, Research and Practice in Thrombosis and Haemostasis (RPTH), naming Mary Cushman, MD, MSc, as its inaugural Editor-In-Chief. Dr. Cushman, a member of the CVRI Board of Directors, is professor of medicine in the Hematology/Oncology Division of the UVM Department of Medicine and Director of the Thrombosis and Hemostasis Program at The UVM Medical Center.

RTPH will publish a broad array of article types covering the widest possible spectrum of topics in thrombosis, hemostasis, and related areas, including studies by multidisciplinary research groups from emerging areas of research and under-represented regions of the world as well as studies and trials covering quality of care, outcomes, and dissemination and implementation science.

Click here to visit the RPTH homepage.

Pioneering Heart Failure Discovery

More than 15 years ago, David Warshaw, PhD, and coworkers discovered the precise malfunction of a specific protein in the heart that leads to hypertrophic cardiomyopathy (HCM). An inherited disease, HCM can cause the heart to thicken and stop pumping blood effectively, leading to heart failure.  Now, a team of scientists has used some of Warshaw’s earlier findings to develop a possible therapy to prevent HCM. Warshaw, professor and chair of molecular physiology and biophysics at UVM and a Director of CVRI, wrote about the significance of this potential therapy for a “Perspectives” column in the February 5, 2016 issue of the journal Science. This may offer a generalized approach to solving hypertrophic cardiomyopathy,” says Warshaw. I think it’s extremely promising."

Read Dr. Warshaw’s column and the report.